CVE-2025-3840
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
An improper neutralization of input vulnerability was identified in the End of Life (EOL) OVA based connect installer component which is deployed for installation purposes in a customer network. This EOL component was deprecated in September 2023 with end of support extended till January 2024. An actor can manipulate the action parameter of the login form to inject malicious scripts which would lead to a XSS attack under certain conditions.
Attack profile
How easy it is to exploit
- Attack vector
- Adjacent network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Passive
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
An improper neutralization of input vulnerability was identified in the End of Life (EOL) OVA based connect installer component which is deployed for installation purposes in a customer network. This EOL component was deprecated in September 2023 with end of support extended till January 2024. An actor can manipulate the action parameter of the login form to inject malicious scripts which would lead to a XSS attack under certain conditions.
- Record
CVE-2025-3840- CVSS 4.0
- 2.1 Low
CVSS:4.0/AV:A/AC:L/AT:P/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N - Weakness
- CWE-79
- Updated
- 2026-11-02
EUVDEUVD-2025-12379
An improper neutralization of input vulnerability was identified in the End of Life (EOL) OVA based connect installer component which is deployed for installation purposes in a customer network. This EOL component was deprecated in September 2023 with end of support extended till January 2024. An actor can manipulate the action parameter of the login form to inject malicious scripts which would lead to a XSS attack under certain conditions.
- Record
EUVD-2025-12379- CVSS 4.0
- 2.1 Low
CVSS:4.0/AV:A/AC:L/AT:P/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-rx59-94qj-gp9f
An improper neutralization of input vulnerability was identified in the End of Life (EOL) OVA...
An improper neutralization of input vulnerability was identified in the End of Life (EOL) OVA based connect installer component which is deployed for installation purposes in a customer network. This EOL component was deprecated in September 2023 with end of support extended till January 2024. An actor can manipulate the action parameter of the login form to inject malicious scripts which would lead to a XSS attack under certain conditions.
- Record
GHSA-rx59-94qj-gp9f- CVSS 4.0
- 2.1 Low
CVSS:4.0/AV:A/AC:L/AT:P/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - Weakness
- CWE-79
- Updated
- 2026-11-02
NVD
An improper neutralization of input vulnerability was identified in the End of Life (EOL) OVA based connect installer component which is deployed for installation purposes in a customer network. This EOL component was deprecated in September 2023 with end of support extended till January 2024. An actor can manipulate the action parameter of the login form to inject malicious scripts which would lead to a XSS attack under certain conditions.
- Record
CVE-2025-3840- CVSS 4.0
- 2.1 Low
CVSS:4.0/AV:A/AC:L/AT:P/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2025-3840 is a low vulnerability (CVSS 2.1) in Saviynt Ova Based Connect, published April 21, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.25%, the 17th percentile. No source names a fixed version.